Product Overview
SL-01 | T19779 | TargetMol Chemicals
CAS: 26049-94-5
Smiles: ClCC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1
Formula: C18H18ClNO3
Pathway: N/A
Target: N/A
Receptor: N/A
Bioactivity: SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.
Molecular Weight: 331, 8
